1977
DOI: 10.1016/s0140-6736(77)93006-9
|View full text |Cite
|
Sign up to set email alerts
|

Melanocyte-Stimulating-Hormone Levels in Doxorubicin-Induced Hyperpigmentation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
1
1

Year Published

1980
1980
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(8 citation statements)
references
References 6 publications
0
6
1
1
Order By: Relevance
“…It has been speculated that suppression of adrenal function by doxorubicin may cause an excess of melanocyte-stimulating hormone (MSH) by the pituitary gland. However, serum MSH and plasma cortisol levels have been reported to be normal (9). Plasma cortisol and a-MSH levels in the present patient were also normal.…”
Section: Discussioncontrasting
confidence: 44%
See 1 more Smart Citation
“…It has been speculated that suppression of adrenal function by doxorubicin may cause an excess of melanocyte-stimulating hormone (MSH) by the pituitary gland. However, serum MSH and plasma cortisol levels have been reported to be normal (9). Plasma cortisol and a-MSH levels in the present patient were also normal.…”
Section: Discussioncontrasting
confidence: 44%
“…The commonest site is the nails (1-4). It can also develop on the palms and soles (5,6), tongue (6,7), buccal mucosa (5) or face (9). Total body pigmentation has also been reported (4).…”
Section: Discussionmentioning
confidence: 99%
“…In general, cancer chemotherapy-induced hyperpigmentation is independent of adrenocorticotrophic hormone (ACTH) and melanocyte stimulating hormone (MSH) activity (11,12). The level of these hormones after 5-FU administration was not measured.…”
Section: Electron Microscopic Findingsmentioning
confidence: 99%
“…An isolated elevation of MSH is unlikely to occur, however, since ß-lipotropin, which contains MSH, and corticotropin are nearly always secreted in parallel.8 Fur¬ thermore, in the only two cases of doxorubicin-induced nail banding in which MSH was assayed, neither a-nor /3-MSH levels were elevated. 6 The distribution and hyperemic appearance of the hyperpigmentation in the patient we describe suggests that daunorubicin may increase the response of melanocytes to UV radiation. That the reaction involved chiefly exposed areas of skin and occurred during the summer in a subtropical region also support the possibility that the drug altered the patient's photosensitivity.…”
Section: Commentmentioning
confidence: 65%